SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-123487
Filing Date
2016-09-12
Accepted
2016-09-12 06:15:17
Documents
1
Period of Report
2016-09-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v448622_8-k.htm 8-K 14620
  Complete submission text file 0001144204-16-123487.txt   15673
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 161879917
SIC: 2834 Pharmaceutical Preparations